NVNiranjan Vijayakumar

Niranjan Vijayakumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Niranjan Vijayakumar has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Good Practice Concepts in Pediatric Critical Care Point-of-Care Ultrasound: A Modified Delphi Consensus Initiative

    by Jamie S. Penk, Vidit Bhargava, Harsha Chandnani, Grace Chong, Thomas Conlon, Ryan L. DeSanti, J. Wesley Diddle, Alejandro Floh, Saul Flores, Anyir Hsieh, et al.

    OBJECTIVE: We assembled a workgroup within the Pediatric Research Collaborative on Critical UltraSound (PeRCCUS), a subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), to define early guidance for point-of-care ultrasound (POCUS) institutional practice and foster future comprehensive guidelines for its broad adoption in pediatric critical care medicine. DESIGN: A modified Delphi method was used for creating the statements. The first meeting was an open proposal session for workgroup members to suggest items for consideration. This was followed by a cycle of voting for levels of agreement along a 7-point Likert-type scale. Items were reviewed, with only items receiving a score of greater than or equal to 6 progressing to the next stage of voting and lower-scoring items reconsidered, with only consensus items proceeding to the next stage for additional rounds of voting until consensus was reached. SETTING: Multi-institutional, multidisciplinary, workgroup of experts on POCUS organized within PeRCCUS as a subgroup of PALISI. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Consensus was obtained for 25 recommendations across five domains: clinical application, quality assurance, equipment, education, and research. CONCLUSIONS: We report consensus recommendations for institutions on clinical use, educational programs, quality assurance, technical requirements, and future research opportunities for the adoption of pediatric critical care medicine POCUS.


  • Open Access

    Blood Product Transfusion and Coagulopathy in Children with Traumatic Brain Injury: A Narrative Review

    by Robert Marcel T. Huibonhoa, Niranjan Vijayakumar, Daniel Kelly, Oliver Karam, Madhuradhar Chegondi

    Traumatic brain injury (TBI) is a leading cause of critical illness and mortality in children. Transfusion of blood products, a common intervention in the management of pediatric TBI, has important implications for related principles, including trauma-induced coagulopathy, cerebral perfusion, and cerebral oxygen delivery. Knowledge gaps persist due to the limited availability of pediatric-specific data regarding blood product transfusion in TBI. In particular, there is a lack of prospective studies defining appropriate specific laboratory thresholds and transfusion targets, as well as insufficient evidence to guide the weighing of potential benefits against transfusion-related risks in this population. Although blood product transfusion in pediatric TBI has been associated with worse clinical outcomes, the underlying mechanisms and contributing factors remain poorly understood. In this review, we aimed to describe the pediatric literature on component and whole blood product transfusion in children with TBI and the pathophysiological mechanisms underlying the development of coagulopathy in this population. In addition, we incorporated available pediatric guidelines and recommendations specific to the setting of acute brain injury.

  • Open Access

    Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children

    by Madhuradhar Chegondi, Niranjan Vijayakumar, Balagangadhar R. Totapally

    Extracorporeal Membrane Oxygenation (ECMO) is often used in critically ill children with severe cardiopulmonary failure. Worldwide, about 3600 children are supported by ECMO each year, with an increase of 10% in cases per year. Although anticoagulation is necessary to prevent circuit thrombosis during ECMO support, bleeding and thrombosis are associated with significantly increased mortality risk. In addition, maintaining balanced hemostasis is a challenging task during ECMO support. While heparin is a standard anticoagulation therapy in ECMO, recently, newer anticoagulant agents are also in use. Currently, there is a wide variation in anticoagulation management and diagnostic monitoring in children receiving ECMO. This review intends to describe the pathophysiology of coagulation during ECMO support, review of literature on current and newer anticoagulant agents, and outline various diagnostic tests used for anticoagulation monitoring. We will also discuss knowledge gaps and future areas of research.


  • Performance of Platelet Mass Index as a Marker of Severity for Sepsis and Septic Shock in Children

    by Madhuradhar Chegondi, Niranjan Vijayakumar, Ramya Deepthi Billa, Aditya Badheka, Oliver Karam

    Platelet mass index (PMI) as a prognostic indicator in pediatric sepsis has not been previously reported. In this retrospective observational study, we evaluated PMI's performance as a prognostic indicator in children aged younger than 18 years with sepsis and septic shock in relationship with survival. Over 5 years, we collected data from 122 children admitted to our pediatric intensive care unit (PICU). PMI accuracy was assessed with sensitivity and specificity and its discrimination was assessed using the area under the receiver operating characteristic curve (AUC). Median PMI values on days 1 and 3 of PICU admission were lower among nonsurvivors. On day 1 of PICU admission, a cutoff PMI value of 1,450 fL/nL resulted in a sensitivity of 72% and a specificity of 69%, and the AUC was 0.70 (95% confidence interval [CI]: 0.55–0.86). Similarly, on day 3, a cutoff of 900 fL/nL resulted in a sensitivity of 71% and a specificity of 70%, and the AUC was 0.76 (95% CI: 0.59–0.92). Our exploratory study suggests that low PMI in children with septic shock is associated with increased mortality. Considering the PMI's fair performance, further studies should be performed to assess its clinical value.


  • NEONATAL MYOCARDIAL INFARCTION

    by Janelle Buysse, Rabia Khan, Osamah Aldoss, Niranjan Vijayakumar, Bassel Mohammad Nijres


  • A Rare Inflammatory Myofibroblastic Tumor of the Mitral Valve With Systemic Embolism in a Child

    by Niranjan Vijayakumar, Bijoy Thattaliyath, Bilge Dundar, Mohsen Karimi, Aditya Badheka, Madhuradhar Chegondi

    Inflammatory myofibroblastic tumors (IMTs) represent mesenchymal tumors that occur in the lungs, abdomen, or pelvis. Cardiac IMTs are rare, usually right-sided, and when left-sided can cause sudden cardiac death by coronary occlusion. We report a child with symptoms of embolization to the right kidney and the femoral artery, and a mobile mass in the left atrium attached to the mitral valve. Upon surgical removal, histopathology revealed IMT. Our case illustrates a unique presentation of systemic thromboembolism.


  • Open Access

    Optimizing a Piezoelectric Energy Harvesting System

    by Anant R. Voleti, Shivam K. Singh, D. R. S Raghuraman, Niranjan Vijayakumar, D Tanushree, A.S.S Balan

    The piezoelectric effect, through which some materials can convert mechanical stress to electrical energy and vice versa, sees a wide array of applications due to its ease of implementation and effectiveness at smaller scales. Piezoelectric materials have emerged in applications such as structural health monitoring and piezo-based smart structures. One such application is energy harvesting; piezoelectric materials can be used to provide power for micro scale devices, in part due to their high efficiency. However, the significantly lower power output of these transducers limits their applicability. This study focuses on comparing different configurations of a piezoelectric energy harvesting system for a motor. By modelling several configurations, this study aims to identify the configuration with the highest sustainable power output.


  • Successful use of Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricular support for acute respiratory distress syndrome in an adolescent with complex congenital heart disease

    by Niranjan Vijayakumar, Aditya Badheka, Madhuradhar Chegondi, Daniel Mclennan

    Rescuing patients with the development of acute respiratory distress syndrome and right heart failure after left ventricular assist device placement remains a challenge in patients with congenital heart disease. TandemLife Protek Duo (TandemLife, Pittsburg, PA) is a double-lumen cannula introduced via the internal jugular vein that can provide veno-venous extra-corporeal membrane oxygenation and right heart support. To our knowledge, we report the first case of successfully using the TandemLife Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricle support in an adolescent male with an existing right ventricle-pulmonary artery conduit and the melody pulmonary valve who developed severe acute respiratory distress syndrome after the placement of left ventricular assist device. The stability of the cannula enabled minimal recirculation-related hypoxia events, early mobilization, and ambulation. Our patient was discharged home after lung recovery and currently awaiting a heart transplant.